Will Ilumya Kill Valeant's Psoriasis Dreams?


If it markets Ilumya on par with VRX's Siliq it could compensate for its late entrance to the psoriasis market. Las month the FDA approved Sun Pharma's Ilumya for the treatment of moderate-to-severe plaque psoriasis: India's largest drug marker, Sun Pharmaceuticals Ltd Wednesday said the US Food and Drug Administration has approved its drug ILUMYA for the treatment of moderate-to-severe plaque psoriasis.



from Biotech News